Glenmark sells rights to new drug to Sanofi

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Glenmark sells rights to new drug to Sanofi

Postby MSUK » Mon May 16, 2011 8:01 am

Image

India's Glenmark Pharmaceuticals said it has agreed to license out development and commercialization rights of a biologic treatment it is developing to France's Sanofi-Aventis S.A.

The drug, code-named GBR500, is aimed at treating Crohn's disease and other inflammatory conditions such as multiple sclerosis, the company said in a statement.

The announcement sent Glenmark's shares to a one-month high as the agreement is expected to revive investor interest in the company's drug discovery and research program, which has been hit by the slow pace of fresh licensing deals and some contract terminations in the past few years............ Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2479
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2120
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service